Miller DM - Search Results

1

Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute.

Viguera AC, Fan Y, Thompson NR, Lapin B, Chaitoff A, Griffith SD, Miller DM, Jehi L, Katzan IL. Viguera AC, et al. Among authors: miller dm. Psychosomatics. 2018 Jul-Aug;59(4):369-378. doi: 10.1016/j.psym.2017.12.003. Epub 2017 Dec 13. Psychosomatics. 2018. PMID: 29580558

2

Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database.

Miller DM, Thompson NR, Cohen JA, Fox RJ, Hartman J, Schwetz K, Conway DS, Rudick RA. Miller DM, et al. Mult Scler. 2015 Apr;21(4):457-65. doi: 10.1177/1352458514544536. Epub 2014 Aug 11. Mult Scler. 2015. PMID: 25112816

3

Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.

Miller DM, Bethoux F, Victorson D, Nowinski CJ, Buono S, Lai JS, Wortman K, Burns JL, Moy C, Cella D. Miller DM, et al. Mult Scler. 2016 May;22(6):830-41. doi: 10.1177/1352458515599450. Epub 2015 Aug 3. Mult Scler. 2016. PMID: 26238464 Free PMC article.

4

Heterogeneous depression trajectories in multiple sclerosis patients.

Gunzler DD, Morris N, Perzynski A, Ontaneda D, Briggs F, Miller D, Bermel RA. Gunzler DD, et al. Mult Scler Relat Disord. 2016 Sep;9:163-9. doi: 10.1016/j.msard.2016.08.004. Epub 2016 Aug 5. Mult Scler Relat Disord. 2016. PMID: 27645367 Free PMC article.

5

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.

McGinley MP, Cola PA, Fox RJ, Cohen JA, Corboy JJ, Miller D. McGinley MP, et al. Mult Scler. 2020 Oct;26(12):1581-1589. doi: 10.1177/1352458519867314. Epub 2019 Aug 1. Mult Scler. 2020. PMID: 31368401

6

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.

Miller DM, Weinstock-Guttman B, Béthoux F, Lee JC, Beck G, Block V, Durelli L, LaMantia L, Barnes D, Sellebjerg F, Rudick RA. Miller DM, et al. Mult Scler. 2000 Aug;6(4):267-73. doi: 10.1177/135245850000600408. Mult Scler. 2000. PMID: 10962547

7

Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.

Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Miller DM, et al. Arch Neurol. 2000 Sep;57(9):1319-24. doi: 10.1001/archneur.57.9.1319. Arch Neurol. 2000. PMID: 10987899

8

Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.

Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N. Miller DM, et al. Mult Scler. 2003 Feb;9(1):1-5. doi: 10.1191/1352458503ms888oa. Mult Scler. 2003. PMID: 12617260 Clinical Trial.

9

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Marrie RA, Miller DM, Chelune GJ, Cohen JA. Marrie RA, et al. Among authors: miller dm. Mult Scler. 2003 Dec;9(6):621-6. doi: 10.1191/1352458503ms971oa. Mult Scler. 2003. PMID: 14664477

10

Association of fatigue and brain atrophy in multiple sclerosis.

Marrie RA, Fisher E, Miller DM, Lee JC, Rudick RA. Marrie RA, et al. Among authors: miller dm. J Neurol Sci. 2005 Feb 15;228(2):161-6. doi: 10.1016/j.jns.2004.11.046. Epub 2004 Dec 21. J Neurol Sci. 2005. PMID: 15694198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters